NSF awards $104M to the creation of four new research centers (including one led by Penn)

Posted on August 7, 2020 — Jessica Jones Gupta

The U.S. National Science Foundation is investing $104 million in four new engineering research centers over the next five years.  Each center will have a specific research focus. Penn is one of the Principal Investigator, under the direction of Dr. Cherie Kagan, of the new NSF Engineering Research Center for the Internet of Things for…

Webinar Recording: SBIR/STTR Resources to Bring Your Technology from Lab to Market

Posted on August 5, 2020 — Jessica Jones Gupta

The Penn Center for Innovation and the National Cancer Institute’s SBIR Development Center hosted a webinar to discuss resources and funding for researchers on August 3, 2020.     The last few months have been challenging for the small business and research communities, which has motivated the NCI SBIR Development Center to create new opportunities…

Penn-affiliated companies included in the list of PACT Enterprise Award Finalists

Posted on — Jessica Jones Gupta

The Philadelphia Alliance for Capital and Technologies (PACT) has announced the finalists for their annual awards.  The list of finalists include four companies affiliated with Penn and the Pennovation Center (the companies are highlighted below in purple). Register for the award ceremony here.   2020 PACT Enterprise Awards Finalists Healthcare Innovator Quantitative Radiology Solutions Spirovant…

Watch the Life Science PA Annual Award Presentation

Posted on August 3, 2020 — Jessica Jones Gupta

Due to the ongoing public health crisis, Life Science PA had to convert their annual awards dinner into a virtual celebration.  The video below features several Penn spinouts and partners including: Scientific Achievement Award: Dr. Jean Bennett, a professor of ophthalmology at the University of Pennsylvania Perelman School of Medicine. Bennett’s lab developed the gene therapy treatment for…

CARISMA Therapeutics announces FDA Clearance of IND Application for first-ever engineered Macrophage Immunotherapy

Posted on July 28, 2020 — Jessica Jones Gupta

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for the Company’s lead product candidate, CT-0508, an anti-human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M). Under this IND, CARISMA…

Medtech company Headway won Pennovation Accelerator’s 2020 virtual pitch day

Posted on July 27, 2020 — Jessica Jones Gupta

Pennovation Center’s third accelerator ended with two startups winning prizes, including one that seeks to improve the way surgeons communicate with each other during minimally invasive surgery. Read article on Technical.ly Philly

Penn to co-lead $6.5M transatlantic grant to investigate the role of the immune system in heart disease

Posted on July 23, 2020 — Jessica Jones Gupta

The international team of researchers will focus on inflammation and the role different cells in the immune system play in cardiovascular health. Read the full press release

Pennovation Accelerator moves online

Posted on July 22, 2020 — Jessica Jones Gupta

In its third summer, the six-week program for startup companies went entirely virtual, but that didn’t stop the cohort of entrepreneurs from learning, networking, and innovating. Read More on Penn Today

Detkin Intellectual Property and Technology Legal Clinic

Posted on July 21, 2020 — Jessica Jones Gupta

Applications are open now! Free transactional intellectual property counsel at Penn Carey Law! We are now accepting clients for the new semester of the Clinic. What is a clinic? A “teaching law-firm” where Penn Carey Law students represent without charge under the supervision of faculty-practitioners. What work can we do? Audit technology, innovation or artistic…

Spark ‘very encouraged’ by gene therapy data, targets 2021 for pivotal study

Posted on July 20, 2020 — Jessica Jones Gupta

Spark Therapeutics expects to begin patient dosing next year in a pivotal study for its next gene therapy candidate. The experimental gene therapy is being developed as a treatment for hemophilia A. Read More on the Philadelphia Business Journal